Europe Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
The Europe organoids market is expected to grow from US$ 1,018.12 million in 2023 to US$ 2,718.25 million by 2028. It is estimated to record a CAGR of 21.7% from 2023 to 2028.
Growing Adoption of Personalized Drugs Fuels Europe Organoids Market
Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease.
The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.
Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor’s genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.
Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.
Europe Organoids Market Overview
The Europe organoids market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The market growth is associated with the rising demand for tissue engineering and organ transplantation; increasing adoption of organoids for disease modeling, gene mutation, and tumor modeling; and growing research activities on organoids. In addition, factors such as increased funding and public-private investments are likely to offer more opportunities to market players in the coming years.
Europe Organoids Market Revenue and Forecast to 2028 (US$ Million
Europe Organoids Market Segmentation
The Europe organoids market is segmented on the basis of type, application, source, and country.
Based on type, the market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment registered the largest market share in 2023.
Based on application, the Europe organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest market share in 2023.
Based on source, the Europe organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger market share in 2023.
Based on country, the Europe organoids market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2023.
Cellesce Ltd; Corning Inc; Definigen; Hubrecht Organoids Technology; InSphero; Merck kGaA; Organoid Therapeutics; PeproTech, Inc.; STEMCELL Technologies Inc; and Thermo Fisher Scientific Inc are the leading companies operating in the organoids market in Europe.
Growing Adoption of Personalized Drugs Fuels Europe Organoids Market
Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease.
The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.
Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor’s genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.
Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.
Europe Organoids Market Overview
The Europe organoids market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The market growth is associated with the rising demand for tissue engineering and organ transplantation; increasing adoption of organoids for disease modeling, gene mutation, and tumor modeling; and growing research activities on organoids. In addition, factors such as increased funding and public-private investments are likely to offer more opportunities to market players in the coming years.
Europe Organoids Market Revenue and Forecast to 2028 (US$ Million
Europe Organoids Market Segmentation
The Europe organoids market is segmented on the basis of type, application, source, and country.
Based on type, the market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment registered the largest market share in 2023.
Based on application, the Europe organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest market share in 2023.
Based on source, the Europe organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger market share in 2023.
Based on country, the Europe organoids market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the market share in 2023.
Cellesce Ltd; Corning Inc; Definigen; Hubrecht Organoids Technology; InSphero; Merck kGaA; Organoid Therapeutics; PeproTech, Inc.; STEMCELL Technologies Inc; and Thermo Fisher Scientific Inc are the leading companies operating in the organoids market in Europe.
1. INTRODUCTION
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Organoids Market – by Type
1.3.2 Europe Organoids Market – by Application
1.3.3 Europe Organoids Market – by Source
1.3.4 Europe Organoids Market – by Country
2. ORGANOIDS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE ORGANOIDS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert’s Opinion
5. EUROPE ORGANOIDS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modelling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. ORGANOIDS MARKET – EUROPE ANALYSIS
6.1 Europe Organoids Market Revenue Forecast and Analysis
7. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Europe Organoids Market Revenue Share, by Type (2022 and 2028)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 Europe Organoids Market Revenue Share, by Application (2022 and 2028)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY SOURCE
9.1 Overview
9.2 Europe Organoids Market Revenue Share, by Source (2022and 2028)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Europe Organoids Market
10.1.1 Overview
10.1.2 Europe Organoids Market, by Country, 2022 & 2028 (%)
10.1.2.1 UK: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 UK: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 UK: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.1.4 UK: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.1.5 UK: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.2 Germany: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Germany: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Germany: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.2.4 Germany: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.2.5 Germany: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.3 France: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 France: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 France: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.3.4 France: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.3.5 France: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.4 Spain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Spain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 Spain: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.4.4 Spain: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.4.5 Spain: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.5 Italy: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Italy: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 Italy: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.5.4 Italy: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.5.5 Italy: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.6 Rest of Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.6.4 Rest of Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.6.5 Rest of Europe Organoids Market, by Source 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 STEMCELL Technologies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cellesce Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Hubrecht Organoid Technology
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Definigen
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PeproTech, Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Corning Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Merck KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 InSphero
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Organoids Market – by Type
1.3.2 Europe Organoids Market – by Application
1.3.3 Europe Organoids Market – by Source
1.3.4 Europe Organoids Market – by Country
2. ORGANOIDS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE ORGANOIDS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert’s Opinion
5. EUROPE ORGANOIDS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modelling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. ORGANOIDS MARKET – EUROPE ANALYSIS
6.1 Europe Organoids Market Revenue Forecast and Analysis
7. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Europe Organoids Market Revenue Share, by Type (2022 and 2028)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 Europe Organoids Market Revenue Share, by Application (2022 and 2028)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY SOURCE
9.1 Overview
9.2 Europe Organoids Market Revenue Share, by Source (2022and 2028)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10. EUROPE ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Europe Organoids Market
10.1.1 Overview
10.1.2 Europe Organoids Market, by Country, 2022 & 2028 (%)
10.1.2.1 UK: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 UK: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 UK: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.1.4 UK: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.1.5 UK: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.2 Germany: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Germany: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Germany: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.2.4 Germany: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.2.5 Germany: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.3 France: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 France: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 France: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.3.4 France: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.3.5 France: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.4 Spain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Spain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 Spain: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.4.4 Spain: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.4.5 Spain: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.5 Italy: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Italy: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 Italy: Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.5.4 Italy: Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.5.5 Italy: Europe Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.6 Rest of Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Europe Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.6.4 Rest of Europe Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.6.5 Rest of Europe Organoids Market, by Source 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 STEMCELL Technologies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cellesce Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Hubrecht Organoid Technology
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Definigen
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PeproTech, Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Corning Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Merck KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 InSphero
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. UK Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 3. UK Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 7. France Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. France Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. France Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. Spain Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Spain Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 12. Spain Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms
Table 1. UK Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 3. UK Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 7. France Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. France Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. France Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. Spain Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Spain Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 12. Spain Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Organoids Market Segmentation
Figure 2. Europe Organoids Market by Country
Figure 3. Europe Organoids Market Overview
Figure 4. Intestine is The Largest Share of Type Segment in Europe Organoids Market
Figure 5. The UK Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts’ Opinion
Figure 8. Europe Organoids Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Organoids Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Europe Organoids Market Revenue Share, by Type (2022 and 2028)
Figure 11. Stomach: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Intestine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Liver: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pancreas: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lung: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Brain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Kidney: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Organoids Market Revenue Share, by Application (2022 and 2028)
Figure 20. Developmental Biology: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Regenerative Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Organoids Market Revenue Share, by Source (2022 and 2028)
Figure 27. Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Organoids Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Europe Organoids Market, by Country, 2022 & 2028 (%)
Figure 31. UK: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Germany: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. France: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Spain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Italy: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies Done by the Companies in the Market, (%)
Figure 1. Europe Organoids Market Segmentation
Figure 2. Europe Organoids Market by Country
Figure 3. Europe Organoids Market Overview
Figure 4. Intestine is The Largest Share of Type Segment in Europe Organoids Market
Figure 5. The UK Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts’ Opinion
Figure 8. Europe Organoids Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Organoids Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Europe Organoids Market Revenue Share, by Type (2022 and 2028)
Figure 11. Stomach: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Intestine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Liver: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pancreas: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lung: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Brain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Kidney: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Organoids Market Revenue Share, by Application (2022 and 2028)
Figure 20. Developmental Biology: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Regenerative Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Organoids Market Revenue Share, by Source (2022 and 2028)
Figure 27. Pluripotent Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Organoids Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. Europe Organoids Market, by Country, 2022 & 2028 (%)
Figure 31. UK: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Germany: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. France: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Spain: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Italy: Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of Europe Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Growth Strategies Done by the Companies in the Market, (%)
